Yanjing Gao: Clinical Trials

2 trials sponsored by Yanjing Gao, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 41Completed 1

Follow Yanjing Gao: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PPIs and Gastroesophageal Varices in Liver Cirrhosis (PPIs: Proton Pump Inhibitors)
Proton Pump Inhibitors, Placebo - Liver Cirrhosis, Hypertension, Portal
Phase 4CompletedYanjing Gao1062017-05-012021-06-09
The Treatment of Hepatocirrhosis and Portal Hypertension
Endoscopic therapy+ beta blockers, Endoscopic therapy+ PSE+beta blockers, beta blockers - Hepatic Cirrhosis, Portal Hypertension
Not applicableCompletedYanjing Gao1082016-02-012025-02-14

Conditions studied

Hypertension, Portal (2)  ·  Liver Cirrhosis (2)  ·  Hemorrhage (1)  ·  Hypersplenism (1)  ·  Thrombocytopenia (1)

Interventions

Adrenergic beta-Antagonists (1)  ·  Proton Pump Inhibitors (1)

Countries

China (2)

Top investigators

Yanjing Gao Yanjing Gao, PhD.MD (1)

Results publications

PMID 33638769, PMID 37486372